Updated February 19, 2017. There's no right way to study in college. Even students who have the same majors and take the same classes won't need to spend the same amount of time on coursework, because everyone has their own way of learning.
The advent of a new class of drugs known as biologics has revolutionized the treatment of rheumatoid arthritis (RA). These drugs, which include Cimzia, Enbrel, Humira, Kineret, Orencia, Remicade, Rituxan, and Simponi, must be given via self-injection or intravenous infusion in the doctorâs office or hospital. They also can be expensive and are not always covered by insurance.
In 2012, the FDA approved tofacitinib (Xeljanz) a new type of disease-modifying arthritis drug (DMARD). Tofacitinib is approved for patients with moderate-to-severe rheumatoid arthritis who have not been helped by methotrexate.Tofacitinib is the first new DMARD approved in over a decade.ntroduction. Rheumatoid arthritis (RA) is a chronic disease in which various joints in the body are inflamed, leading to swelling, pain, stiffness, and the possible loss of function. Rheumatoid arthritis is an autoimmune disease in which the body's immune system attacks joints and other tissues.